BDX · Healthcare
BECTON DICKINSON & CO
Smart-money confidence
· 1 of 3 sources firing
Weak — few signals
No standout activity across the feeds we track.
Hedge funds
38
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
◆ Next steps
Interested in BECTON DICKINSON & CO? Here's what to do with it.
◇
Compare with other stocks
Sort 7,111 stocks by confidence, holders, or Congress signal
◈
Backtest the strategy
See how the model has done historically before you commit real money
✉
Get the weekly digest
One email on Sunday · what changed in the model this week
Not financial advice. Bogen Capital surfaces public SEC filings — you decide what to do with them.
Market cap
$43.6B
Industry
Medical Instruments & Supplies
Sector
Healthcare
Exchange
NYSE
About BECTON DICKINSON & CO
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free…
Who's behind the signal
Every informed buyer we can see on BDX, across all three feeds.
Hedge funds · 7
AQR Capital Management
Increased +15%
Gotham Asset Mgmt (Greenblatt)
Increased +7%
Citadel Advisors
Increased +43%
Starboard Value
Decreased −23%
Bridgewater Associates (Dalio)
Decreased −5%
Millennium Management (Englander)
Decreased −39%
+1 more in the full breakdown below ↓
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Congressional trade history · 3
Every disclosed buy & sell on record — STOCK Act filings
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2018-04-24 | Shelley M Capito | Senate | BOUGHT | $1,001 - $15,000 |
| 2018-04-05 | Shelley M Capito | Senate | BOUGHT | $1,001 - $15,000 |
| 2016-04-19 | Shelley M Capito | Senate | BOUGHT | $1,001 - $15,000 |
Not a model pick — but on our radar.
BECTON DICKINSON & CO isn't in the top-10 model right now, but 7 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
7
Investors
0
New positions
3
Increasing
4
Decreasing
0
Unchanged
Price History
Loading price data...
Return:
High:
Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.0×
% of portfolio
0.1%
Position change
+15%
0.1% of AQR Capital Management's portfolio
Trust weight: 1.1×
% of portfolio
0.1%
Position change
+7%
0.1% of Gotham Asset Mgmt's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
+43%
0.1% of Citadel Advisors's portfolio
Trust weight: 1.3×
% of portfolio
3.4%
Position change
−23%
3.4% of Starboard Value's portfolio
Trust weight: 1.3×
% of portfolio
0.0%
Position change
−5%
0.0% of Bridgewater Associates's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−39%
0.0% of Millennium Management's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−85%
0.0% of D.E. Shaw & Co's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to BECTON DICKINSON & CO
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell BECTON DICKINSON & CO or any security.
Get the Weekly Update
Every Sunday, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime